Co-Diagnostics (CODX) Revenue & Revenue Breakdown
Co-Diagnostics Revenue Highlights
Latest Revenue (Y)
$6.81M
Latest Revenue (Q)
$641.14K
Main Segment (Y)
Product Revenue
Main Geography (Y)
UNITED STATES
Co-Diagnostics Revenue by Period
Co-Diagnostics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $6.81M | -80.09% |
| 2022-12-31 | $34.22M | -65.04% |
| 2021-12-31 | $97.89M | 31.30% |
| 2020-12-31 | $74.55M | 34579.90% |
| 2019-12-31 | $214.97K | 438.63% |
| 2018-12-31 | $39.91K | 420.90% |
| 2017-12-31 | $7.66K | 100.00% |
| 2016-12-31 | - | -100.00% |
| 2015-12-31 | $10.00K | - |
Co-Diagnostics generated $6.81M in revenue during NA 2023, up -80.09% compared to the previous quarter, and up 17068.07% compared to the same period a year ago.
Co-Diagnostics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-09-30 | $641.14K | 297.97% |
| 2024-06-30 | $161.10K | -36.26% |
| 2024-03-31 | $252.75K | -92.89% |
| 2023-12-31 | $3.56M | 44.69% |
| 2023-09-30 | $2.46M | 1142.18% |
| 2023-06-30 | $197.81K | -67.14% |
| 2023-03-31 | $601.96K | -57.05% |
| 2022-12-31 | $1.40M | -72.49% |
| 2022-09-30 | $5.09M | 1.42% |
| 2022-06-30 | $5.02M | -77.87% |
| 2022-03-31 | $22.70M | 11.26% |
| 2021-12-31 | $20.40M | -32.22% |
| 2021-09-30 | $30.10M | 10.03% |
| 2021-06-30 | $27.36M | 36.62% |
| 2021-03-31 | $20.02M | -26.23% |
| 2020-12-31 | $27.15M | 24.41% |
| 2020-09-30 | $21.82M | -9.24% |
| 2020-06-30 | $24.04M | 1452.46% |
| 2020-03-31 | $1.55M | 1326.35% |
| 2019-12-31 | $108.57K | 162.02% |
| 2019-09-30 | $41.43K | -32.71% |
| 2019-06-30 | $61.57K | 1711.00% |
| 2019-03-31 | $3.40K | -68.59% |
| 2018-12-31 | $10.82K | 11.62% |
| 2018-09-30 | $9.70K | - |
| 2018-06-30 | $9.70K | - |
| 2018-03-31 | $9.70K | 273.21% |
| 2017-12-31 | $2.60K | - |
| 2017-09-30 | $2.60K | 5.35% |
| 2017-06-30 | $2.47K | 100.00% |
| 2017-03-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2016-09-30 | - | 100.00% |
| 2016-06-30 | - | 100.00% |
| 2016-03-31 | - | - |
Co-Diagnostics generated $641.14K in revenue during Q3 2024, up 297.97% compared to the previous quarter, and up 324.13% compared to the same period a year ago.
Co-Diagnostics Revenue Breakdown
Co-Diagnostics Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 |
|---|---|
| Product Revenue | $991.47K |
Co-Diagnostics's latest annual revenue breakdown by segment (product or service), as of Dec 23: Product Revenue (100.00%).
Quarterly Revenue by Product
| Product/Service | Sep 24 | Mar 24 | Dec 23 | Sep 23 |
|---|---|---|---|---|
| Product Revenue | $206.88K | $252.75K | $854.94K | $136.53K |
| Grant Revenue | $434.26K | $215.11K | - | - |
Co-Diagnostics's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Grant Revenue (67.73%), and Product Revenue (32.27%).
Co-Diagnostics Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|
| UNITED STATES | $659.62K | $24.67M | - | - |
| Rest of World | $331.86K | $9.55M | $45.70M | $29.69M |
| Americas | - | - | $52.19M | - |
| United States | - | - | - | $44.86M |
Co-Diagnostics's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (66.53%), and Rest of World (33.47%).
Quarterly Revenue by Country
| Country | Sep 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rest of World | $77.10K | $166.45K | $14.05K | $48.43K | $60.58K | $208.80K | $155.12K | $395.01K | $523.87K | $8.48M | $2.92M | $7.53M | $10.43M | $7.76M | - | - |
| UNITED STATES | $564.04K | $301.40K | $41.13K | $88.11K | $137.23K | $393.15K | - | - | - | - | - | - | - | - | - | - |
| Americas | - | - | - | - | - | - | - | $4.70M | $4.50M | $14.22M | $17.48M | $16.91M | $5.37M | - | - | - |
| Rest Of World | - | - | - | - | - | - | - | - | - | - | - | $13.19M | $21.99M | - | - | - |
| United States | - | - | - | - | - | - | - | - | - | - | - | - | - | $12.49M | $16.71M | $14.05M |
Co-Diagnostics's latest quarterly revenue breakdown by geography, as of Sep 24: UNITED STATES (87.97%), and Rest of World (12.03%).
Co-Diagnostics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| INGN | Inogen | $315.66M | $88.83M |
| SRDX | Surmodics | $132.58M | $30.34M |
| NPCE | NeuroPace | $65.42M | $21.06M |
| CVRX | CVRx | $39.30M | $13.37M |
| CLPT | ClearPoint Neuro | $23.95M | $8.12M |
| RPID | Rapid Micro Biosystems | $22.52M | $7.60M |
| HSCS | Heart Test Laboratories | $18.60M | - |
| VVOS | Vivos Therapeutics | $13.80M | $4.05M |
| RSLS | ReShape Lifesciences | $8.68M | $1.97M |
| CODX | Co-Diagnostics | $6.81M | $641.14K |
| NURO | NeuroMetrix | $5.90M | $587.31K |
| OPGN | OpGen | $3.42M | $28.00K |
| INVO | INVO Bioscience | $3.02M | $1.58M |
| NAOV | NanoVibronix | $2.28M | $817.00K |
| TIVC | Tivic Health Systems | $1.18M | $140.00K |
| IINN | Inspira Technologies Oxy B.H.N. | - | - |
| BJDX | Bluejay Diagnostics | - | - |
| NVNO | enVVeno Medical | - | - |
| MOVE | Movano | - | - |
| BBLG | Bone Biologics | - | - |
| BMRA | Biomerica | - | $1.81M |